Concept of the central clip: When to use one or two MitraClips®

EuroIntervention

Volumn 9, Issue 10, 2014, Pages 1217-1224

  Alegria Barrero, Eduardo ^a   Chan, Pak Hei ^a   Foin, Nicolas ^d   Syrseloudis, Dimitrios ^a   Tavazzi, Guido ^b   Price, Susanna ^a   Lindsay, Alistair C ^a   Duncan, Alison ^a   Moat, Neil ^a   Di Mario, Carlo ^a   Franzen, Olaf W ^c  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c University of Copenhagen   (Denmark)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Heart failure; Mitral regurgitation; Percutaneous mitral valve repair

Indexed keywords

AGED; AGED, 80 AND OVER; BLOOD FLOW VELOCITY; CARDIAC CATHETERIZATION; FEASIBILITY STUDIES; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TREATMENT OUTCOME;

EID: 84894448407     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV9I10A204     Document Type: Article

References (23)

1. Franzen O, van der Heyden J, Baldus S, Schlüter M, Schillinger W, Butter C, Hoffmann R, Corti R, Pedrazzini G, Swaans MJ, Neuss M, Rudolph V, Sürder D, Grünenfelder J, Eulenburg C, Reichenspurner H, Meinertz T, Auricchio A. MitraClip® therapy in patients with end-stage systolic heart failure. Eur J Heart Fail. 2011;13:569-76.
2. Maisano F, Franzen O, Baldus S, Hausleiter J, Butter C, Schaefer U, Pedrazzini G, Schillinger W. MitraClip® therapy demonstrates favourable mid-term outcomes in ACCESS-EUROPE heart failure patients with left ventricular ejection fraction 30%: preliminary report from the 6-month ACCESS-EU analysis cohort. EuroIntervention. 2011;7:M397.
3. Alegria-Barrero E, Chan PH, Paulo M, Duncan A, Price S, Moat N, Di Mario C, Serra A, García E, Franzen O. Edge-to-edge percutaneous repair of severe mitral regurgitation - state-of-the-art for Mitraclip® implantation. Circ J. 2012;76:801-8.
4. Mirabel M, Iung B, Baron G, Messika-Zeitoun D, Détaint D, Vanoverschelde JL, Butchart EG, Ravaud P, Vahanian A. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28:1358-65. (Pubitemid 47355974)
5. van den Heuvel AF, Alfieri O, Mariani MA. MitraClip in end-stage heart failure: a realistic alternative to surgery? Eur J Heart Fail. 2011;13:472-4.
6. Otto CM, Verrier ED. Mitral regurgitation - what is best for my patient? N Engl J Med. 2011;364:1462-3.
7. Cabrera-Bueno F, Molina-Mora MJ, Alzueta-Rodriguez FJ. Mitral regurgitation and cardiac resynchronization therapy: how long and what should we expect? Europace. 2011;13:1801-2.
8. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM 3rd, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH; HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241-51.
9. Franzen O, Baldus S, Rudolph V, Meyer S, Knap M, Koschyk D, Treede H, Barmeyer A, Schofer J, Costard-Jäckle A, Schlüter M, Reichenspurner H, Meinertz T. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J. 2010;31:1373-81.
10. Alqoofi F, Feldman T. Percutaneous approaches to mitral regurgitation. Curr Treat Options Cardiovasc Med. 2009;11:476-82.
11. Feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, Smalling R, Whitlow PL, Gray W, Low R, Herrmann HC, Lim S, Foster E, Glower D; EVEREST Investigators. Percutaneous mitral repair with the MitraClip system. J Am Coll Cardiol. 2009;54:686-94.
12. Feldman T, Cilingiroglu M. Percutaneous leaflet repair and annuloplasty for mitral regurgitation. J Am Coll Cardiol. 2011;57:529-37.
13. Taylor J. The percutaneous approach to mitral valve repair. Eur Heart J. 2011;32:249-51.
14. Chan PH, Di Mario C, Franzen O. Dissociation between anatomical and functional results after MitraClip® implantation. Int J Cardiol. 2012;155:175-6.
15. Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E, Loghin C, Trento A, Skipper ER, Fudge T, Letsou GV, Massaro JM, Mauri L; EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364:1395-406.
16. Adams DH, Rosenhek R, Falk V. Degenerative mitral valve regurgitation: best practice revolution. Eur Heart J. 2010;31:1958-66.
17. Altiok E, Becker M, Hamada S, Reith S, Marx N, Hoffmann R. Optimized guidance of percutaneous edge-to edge repair of the mitral valve using real-time 3-D transesophageal echocardiography. Clin Res Cardiol. 2011;100:675-81.
18. Yuksel UC, Kapadia SR, Tuzcu EM. Percutaneous mitral repair: patient selection, results, and future directions. Curr Cardiol Rep. 2011;13:100-6.
19. Borgia F, Di Mario C, Franzen O. Adenosine-induced asystole to facilitate MitraClip placement in a patient with adverse mitral valve morphology. Heart. 2011;97:864.
20. Zamorano JL, Badano LP, Bruce C, Chan KL, Gonçalves A, Hahn RT, Keane MG, La Canna G, Monaghan MJ, Nihoyannopoulos P, Silvestry FE, Vanoverschelde JL, Gillam LD. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. J Am Soc Echocardiogr. 2011;24:937-65.
21. Foster GP, Dunn AK, Abraham S, Ahmadi N, Sarraf G. Accurate measurement of mitral annular dimensions by echocardiography: importance of correctly aligned imaging planes and anatomic landmarks. J Am Soc Echocardiogr. 2009;22:458-63.
22. Grayburn PA. How to measure severity of mitral regurgitation: valvular heart disease. Heart. 2008;94:376-83. (Pubitemid 351303434)
23. Chan PH, She HL, Alegria-Barrero E, Moat N, Di Mario C, Franzen O. Real-world experience of MitraClip for treatment of severe mitral regurgitation. Circ J. 2012;76:2488-93.